HK

Hemant Kulkarni

Active Director Director DIN 02525697
DIN 02525697 First appointment Jun 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2005
Shareholding value •••• Premium profile

About Hemant Kulkarni

Data last updated:

Hemant Kulkarni is a Director at Saphire Biotech Private Limited (since 2005). The company operates in Pharma. Saphire Biotech Private Limited reported revenue of ₹2.36 Cr (FY 2024).

DIN 02525697
Primary Designation Director
Industry Pharma
First Appointment 21 Jun 2005
Oldest Company Age 21 yrs
Largest company Saphire Biotech Private Limited · ₹2.36 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saphire Biotech Private Limited U24246MP2004PTC017081
Director21 Jun 20052004₹2.36 Cr (FY 2024)Active

Board colleagues of Hemant Kulkarni

Directorship timeline

Open interactive timeline →
Saphire Biotech Private Limited
Premium access

Shareholding and investment profile for Hemant Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemant Kulkarni

Hemant Kulkarni currently holds 1 directorship: Saphire Biotech Private Limited (Director, since 21 Jun 2005, revenue ₹2.36 Cr (FY 2024)).

Hemant Kulkarni was first appointed on 21 Jun 2005 as Director at Saphire Biotech Private Limited.

The current boards of Hemant Kulkarni's companies include Ketki Kulkarni (Saphire Biotech Private Limited), Mihir Kulkarni (Saphire Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available